Workflow
深圳惠泰医疗器械股份有限公司2024年年度权益分派实施公告

Core Points - The company announced a cash dividend of 1.75 CNY per share and a stock bonus of 0.45 shares for each share held [2][4] - The profit distribution and capital increase plan was approved at the annual shareholders' meeting on May 13, 2025 [2][3] Distribution and Capital Increase Plan - The distribution is based on a total share capital of 97,250,894 shares, resulting in a total cash dividend payout of 170,189,064.50 CNY (including tax) and an increase of 43,762,902 shares, leading to a new total share capital of 141,013,796 shares [4][12] - The distribution is applicable to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the registration date [3][4] Implementation Details - Cash dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation Limited, with shareholders able to collect their dividends at their designated securities firms [4][6] - The stock bonus will be directly credited to shareholders' accounts based on their holdings as of the registration date [6] Taxation Information - Individual shareholders holding shares for over one year will not be subject to personal income tax on dividends, while those holding for one year or less will have taxes calculated upon the sale of shares [8][9] - For Qualified Foreign Institutional Investors (QFIIs), a 10% corporate income tax will be withheld, resulting in a net cash dividend of 1.575 CNY per share [9][10] Share Capital Structure - All strategic placement shares from the initial public offering have been fully listed and circulated [11] - The diluted earnings per share for the fiscal year 2024, after the stock bonus, is calculated to be 4.77 CNY [12]